Epinephrine Synthesis
Epinephrine (adrenaline) is synthesized primarily in the adrenal medulla through the enzyme phenylethanolamine-N-methyltransferase (PNMT), which converts norepinephrine to epinephrine by adding a methyl group from S-adenosylmethionine 1, 2.
Biochemical Pathway
The synthesis follows this enzymatic cascade:
- Tyrosine → L-DOPA (via tyrosine hydroxylase)
- L-DOPA → Dopamine (via DOPA decarboxylase)
- Dopamine → Norepinephrine (via dopamine β-hydroxylase)
- Norepinephrine → Epinephrine (via PNMT) 2
PNMT is the rate-limiting enzyme for epinephrine synthesis and requires glucocorticoids for its induction and activity 1. The adrenal medulla receives uniquely high concentrations of glucocorticoids through an intra-adrenal portal vascular system, which is essential for maintaining PNMT activity and epinephrine production 1.
Regulation During Stress
During stress, the hypothalamic-pituitary-adrenal axis activates:
- ACTH stimulates the adrenal cortex to release glucocorticoids
- These glucocorticoids induce PNMT expression in the medulla
- Cholinergic nervous input directly stimulates medullary secretion
- This coordinated response increases both epinephrine synthesis and release 1, 2
Chronic stress can enhance PNMT expression and epinephrine synthesis capacity, while pituitary failure that suppresses glucocorticoid secretion compromises epinephrine synthesis 1.
Extraadrenal Synthesis
Recent research demonstrates that multiple tissues can synthesize epinephrine using enzymes distinct from adrenal PNMT 3, 4, 5. The liver, arteries, and other tissues contain N-methyltransferases that can convert norepinephrine to epinephrine, though these enzymes differ from adrenal PNMT in substrate specificity and inhibitor sensitivity 4, 5. After adrenal demedullation, tissue epinephrine levels remain substantial (22-125% of control depending on tissue), indicating significant extraadrenal synthesis 3.
Pharmaceutical Formulation
For clinical use, epinephrine is formulated as a sympathomimetic catecholamine with the chemical structure 1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]- and molecular weight of 183.2 6. The solution deteriorates rapidly on exposure to air or light, turning pink from oxidation to adrenochrome and brown from melanin formation 6, which is why pharmaceutical preparations include stabilizers like sodium metabisulfite and are stored in amber vials 6.